{
    "organizations": [],
    "uuid": "fd7b690b5be1b2931bcd48fe0ee28470ae243d07",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-imprimis-pharmaceuticals-issued-co/brief-imprimis-pharmaceuticals-issued-composition-patent-for-non-opioid-conscious-sedation-formulation-idUSFWN1R90AG",
    "ord_in_thread": 0,
    "title": "BRIEF-Imprimis Pharmaceuticals Issued Composition Patent For Non-Opioid Conscious Sedation Formulation",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 27 (Reuters) - Imprimis Pharmaceuticals Inc:\n* IMPRIMIS PHARMACEUTICALS ISSUED COMPOSITION PATENT FOR NON-OPIOID CONSCIOUS SEDATION FORMULATION\n* IMPRIMIS PHARMACEUTICALS INC - ‍SECURED A PATENT COVERING COMPANY’S MKO MELT COMPOUNDED FORMULATION​ Source text for Eikon: Further company coverage: (Reuters.Brief@thomsonreuters.com)\n ",
    "published": "2018-03-27T19:43:00.000+03:00",
    "crawled": "2018-03-28T19:18:54.012+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "imprimis",
        "pharmaceutical",
        "inc",
        "imprimis",
        "pharmaceutical",
        "issued",
        "composition",
        "patent",
        "conscious",
        "sedation",
        "formulation",
        "imprimis",
        "pharmaceutical",
        "inc",
        "patent",
        "covering",
        "company",
        "mko",
        "melt",
        "compounded",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}